ArticleCancers2025
Patients Who Refuse Blood Transfusions Should Not Be Discouraged from Immediate Direct-to-Implant Breast Reconstruction After Mastectomy: A Retrospective Study on Severe Bleeding Risks.
Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDirect-to-implant breast reconstruction is the most common method for immediate breast restoration after mastectomies performed with prophylactic or curative indications. This approach significantly enhances patients' quality of life without adversely affecting oncological outcomes. However, it remains unclear whether mastectomy with direct-to-implant breast reconstruction (M-DTI) is an optimal option for patients who refuse blood transfusions for religious reasons (e.g., Jehovah's Witnesses) or other personal beliefs.
methodsWe retrospectively reviewed 490 patients who underwent either mastectomy alone (MA) or M-DTI between January 2021 and June 2023. We analyzed patient characteristics, operative details, and rates of bleeding complications.
resultsMA was performed on 220 patients, while mastectomy with immediate breast reconstruction was conducted on 270 patients. Overall, bleeding complications-including those requiring reoperation and/or blood transfusion-occurred in 21 patients. In the MA group, bleeding complications occurred in 2.4% of patients, compared to 1.8% in the M-DTI group (
conclusionsThe findings of this study suggest that immediate breast reconstruction does not increase the risk of bleeding in patients undergoing mastectomy. Therefore, it should also be considered a viable option for patients requiring bloodless medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.